http://rdf.disgenet.org/resource/nanopub/NP657670.RA-JJOGOTTBx9XKNRfYQtpf3IfVfojFgozCHbZvCEgGx0
type: Nanopublication
created: 2016-05-13T12:46:43+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

http://rdf.disgenet.org/resource/nanopub/NP657670.RA-JJOGOTTBx9XKNRfYQtpf3IfVfojFgozCHbZvCEgGx0130_assertion
type: Assertion
description: [Advances in the understanding of the molecular mechanisms implicated in prostate cancer progression have allowed identification of many potential therapeutic gene targets that are involved in apoptosis, growth factors, cell signaling, and the androgen receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/18303483
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0